{
  "event_id": "e37220b13274",
  "ticker": "AMGN",
  "company_name": "Amgen",
  "drug_name": "LUMAKRAS (Sotorasib)",
  "result": "approved",
  "pdufa_date": "2023-04-24",
  "approval_type": {
    "status": "found",
    "value": "nda",
    "source": "websearch:CodeBreaK 100/200",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.108104",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "KRAS G12C mutated NSCLC",
    "source": "websearch:CodeBreaK 100/200",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.108105",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "sotorasib",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Oncology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.451074",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "KRAS G12C inhibitor",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.014446",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:CodeBreaK 100/200",
    "confidence": 0.85,
    "evidence": [
      "CodeBreaK 100/200"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.108091",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "0.002",
    "source": "websearch:CodeBreaK 100/200",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.108098",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "ORR 37%; PFS HR 0.66 vs docetaxel",
    "source": "websearch:CodeBreaK 100/200",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.108100",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "derived_from_resubmission",
    "confidence": 0.85,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 1,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "p_value_numeric": 0.002,
  "nct_ids": [
    "NCT03600883",
    "NCT04303780"
  ],
  "phase3_study_names": [
    "A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)",
    "A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "count": 713,
    "type": "ACTUAL",
    "nct_id": "NCT03600883",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:24:45.742883"
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": false,
    "accelerated_approval": true
  },
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "date": null,
    "outcome": null,
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": true,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=SEQUENTIAL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:35.977481",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['ROMANIA', 'BELGIUM', 'SPAIN', 'PORTUGAL', 'UNITED STATES']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:35.977528",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": false,
    "status": "found",
    "source": "approval_type_nda",
    "confidence": 0.9,
    "tier": 2,
    "evidence": [
      "approval_type=nda"
    ],
    "searched_sources": [
      "approval_type_nda"
    ],
    "last_searched": "2026-01-10T13:11:17.310842",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": "2014-01-27",
    "status": "found",
    "source": "fda.gov",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "Thousand Oaks CA facility - drug/device combo violations (Prolia, Enbrel prefilled syringes)"
    ],
    "searched_sources": [
      "fda.gov"
    ],
    "last_searched": "2026-01-11T04:05:14.882845",
    "error": null,
    "note": null
  },
  "fda_483_date": {
    "value": "2023-05-01",
    "status": "found",
    "source": "redica.com",
    "confidence": 0.8,
    "tier": 3,
    "evidence": [
      "Facility: Thousand Oaks, CA",
      "Outcome: N/A"
    ],
    "searched_sources": [
      "redica.com"
    ],
    "last_searched": "2026-01-11T05:25:26.300036",
    "error": null,
    "facility": "Thousand Oaks, CA"
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:30:58.983602",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:30:59.850866",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -992,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.244908",
  "original_case_id": "440602fa4374",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:25:33.495565",
  "enriched_at": "2026-01-11T17:33:03.147585",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.014470",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "FDA panel sceptical on Lumakras confirmatory data - pharmaphorum",
      "Oct. 5 Quick Takes: FDA panel declines to back Lumakras",
      "Vote ratio extracted: 83.3%"
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:33:03.147575"
  },
  "adcom_vote_ratio": {
    "value": 0.8333333333333334,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [
      "FDA panel sceptical on Lumakras confirmatory data - pharmaphorum",
      "Oct. 5 Quick Takes: FDA panel declines to back Lumakras",
      "Vote ratio extracted: 83.3%"
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:33:03.147582"
  },
  "breakthrough_therapy": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "LUMAKRAS (sotorasib), FDA Approved ... - Biologics by McKesson"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:55.857574",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "FDA grants accelerated approval to sotorasib for KRAS G12C ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:01.996147",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Sotorasib - Wikipedia"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:03.371071",
    "search_status": "FOUND"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Sotorasib - Wikipedia"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:57.257809",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA APPROVES LUMAKRASÂ® (SOTORASIB) IN COMBINATION WITH ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:04.772191",
    "search_status": "FOUND"
  }
}